1240. Persistence of Circulating Antibody Through 12 Months Following Vaccination With a 20-Valent Pneumococcal Conjugate Vaccine in Adults 60–64 Years of Age

BACKGROUND: While widespread use of pneumococcal conjugate vaccines (PCVs) has reduced disease burden, expanding serotype coverage remains an unmet need in disease prevention. The 20-valent PCV (PCV20) contains capsular polysaccharide conjugates from serotypes included in the 13-valent PCV (PCV13; P...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurley, Donald, Griffin, Carl, Young Jr., Mariano, Scott, Daniel, Pride, Michael W, Scully, Ingrid L, Ginis, John, Peng, Yahong, Jansen, Kathrin U, Gruber, William C, Watson, Wendy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776953/
http://dx.doi.org/10.1093/ofid/ofaa439.1425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776953/
http://dx.doi.org/10.1093/ofid/ofaa439.1425

Ejemplares similares